EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extramedullary Escape in Acute Lymphoblastic Leukemia (ALL) After Allogeneic Transplantation: A Practical Guide to Diagnosis and Management

Claudia Simio, Alessandra Vatteroni, Cecilia Grandi

Lymphatics · 07.05.2026 · 4 (2) · 25

DOI: 10.3390/lymphatics4020025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lymphatics, online erschienen am 07.05.2026. Verfasst von Claudia Simio und 2 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extramedullary relapse (EMR) of acute lymphoblastic leukemia (ALL) after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) represents a clinically and biologically distinct entity compared with medullary relapse, characterized by marked heterogeneity, compartmental immune escape mechanisms, and generally poor prognosis. EMR arises at the intersection of clonal resistance, evolutionary disease adaptation, and heterogeneous distribution of the graft-versus-leukemia effect, resulting in evolutionary trajectories that are often dissociated between medullary and extramedullary compartments. In the absence of prospectively validated therapeutic algorithms, EMR management requires a structured and adaptive approach based on multidimensional assessment integrating leukemia biology, disease burden and anatomical distribution, bone marrow minimal residual disease (MRD) status, and immune reconstitution. Therapeutic strategies include local treatments, targeted agents, immunotherapies, and immunomodulatory interventions, applied within a dynamic sequence tailored to treatment response. Follow-up plays a central role as an active tool for prognostic stratification and clinical decision-making, enabling early detection of systemic progression and optimization of the timing of consolidative strategies, including second Allo-HSCT in selected patients. An integrated and biologically driven management of post-Allo-HSCT EMR is essential to improve outcomes in this high-risk clinical setting.

Zitieren

APA

Simio, C., Vatteroni, A., & Grandi, C. (2026). Extramedullary Escape in Acute Lymphoblastic Leukemia (ALL) After Allogeneic Transplantation: A Practical Guide to Diagnosis and Management. Lymphatics, 4(2), 25. https://doi.org/10.3390/lymphatics4020025

Vancouver

Simio C, Vatteroni A, Grandi C. Extramedullary Escape in Acute Lymphoblastic Leukemia (ALL) After Allogeneic Transplantation: A Practical Guide to Diagnosis and Management. Lymphatics. 2026;4(2):25. doi:10.3390/lymphatics4020025

BibTeX
@article{Simio2026,
  author = {Simio, Claudia and Vatteroni, Alessandra and Grandi, Cecilia},
  title = {Extramedullary Escape in Acute Lymphoblastic Leukemia (ALL) After Allogeneic Transplantation: A Practical Guide to Diagnosis and Management},
  journal = {Lymphatics},
  year = {2026},
  volume = {4},
  number = {2},
  pages = {25},
  doi = {10.3390/lymphatics4020025}
}
Kostenlos starten →